Lei Changhai相关文献与解析，生知库 | 链接生命科学的每一步

Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies

针对肿瘤和免疫热点靶点的抗体筛选：新方法和技术的前沿

期刊:

影响因子:

doi:10.1016/j.jpha.2025.101417

Zhou, Yaping; Zou, Yitan; Lv, Shaodong; Tan, Dan; Li, Guangyao; Fu, Wenyan; Lei, Changhai; Lu, Mingdong; Hu, Shi

T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 Infection.

T细胞依赖性双特异性IgG保护老年小鼠免受致命的SARS-CoV-2感染

期刊:Advanced Science

影响因子:14.1

doi:10.1002/advs.202406980

Fu Wenyan, Zhang Wei, You Zhongshuai, Li Guangyao, Wang Chuqi, Lei Changhai, Zhao Jian, Hou Jin, Hu Shi

The application of antibody-based agents in cancer therapy based on their mechanisms of action

基于抗体药物作用机制的癌症治疗应用

期刊:Fundamental Research

影响因子:6.3

doi:10.1016/j.fmre.2024.02.021

Qian, Kewen; Li, Guangyao; Zhang, Shuyi; Zou, Yitan; Ai, Hongru; Zheng, Xinya; Fu, Wenyan; Lei, Changhai; Hu, Shi

Dual-target immunotherapies in NSCLC: a systematic review and meta-analysis of randomized clinical trials

非小细胞肺癌双靶点免疫疗法：随机临床试验的系统评价和荟萃分析

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2025.1605877

Zhang, Yike; Wang, Haozhe; Yang, Xinyue; Lei, Changhai

Protective effects of an Fc-engineered PD-L1 fusion protein in a spontaneous abortion model and a Th17 cell-induced pregnancy loss model

Fc工程化PD-L1融合蛋白在自然流产模型和Th17细胞诱导的妊娠丢失模型中的保护作用

期刊:Frontiers in Pharmacology

影响因子:4.8

doi:10.3389/fphar.2025.1703805

Li, Guangyao; Wang, Tiantian; Tan, Dan; Jin, Yamin; Zhou, Xuemei; Ai, Hongru; Zheng, Xinya; Ren, Xiaochen; Hu, Shi; Lei, Changhai; Fu, Wenyan

Small extracellular vesicles purification and scale-up

小细胞外囊泡的纯化和放大

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1344681

Zheng, Xinya; Ai, Hongru; Qian, Kewen; Li, Guangyao; Zhang, Shuyi; Zou, Yitan; Lei, Changhai; Fu, Wenyan; Hu, Shi

Exosomes: the next frontier in vaccine development and delivery

外泌体：疫苗研发和递送的下一个前沿领域

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1435426

Tan, Dan; Li, Guangyao; Fu, Wenyan; Lei, Changhai

外泌体

发表日期：2024

文献求助收藏

The therapeutic potential of exosomes in immunotherapy

外泌体在免疫治疗中的治疗潜力

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1424081

Li, Guangyao; Zhang, Shuyi; Zou, Yitan; Ai, Hongru; Zheng, Xinya; Qian, Kewen; Lei, Changhai; Fu, Wenyan

Engineered soluble ACE2 receptor: Responding to change with change

工程化可溶性ACE2受体：以变革应对变革

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2022.1084331

Li, Guangyao; Qian, Kewen; Zhang, Shuyi; Fu, Wenyan; Zhao, Jian; Lei, Changhai; Hu, Shi

Development of CAR Exosomes Targeting FAP for the Treatment of Intrauterine Adhesion

开发靶向FAP的CAR外泌体用于治疗宫腔粘连

Antibody screening for tumor and immune hotspot targets: The frontier of new methods and technologies

针对肿瘤和免疫热点靶点的抗体筛选：新方法和技术的前沿

T-Cell-Dependent Bispecific IgGs Protect Aged Mice From Lethal SARS-CoV-2 Infection.

T细胞依赖性双特异性IgG保护老年小鼠免受致命的SARS-CoV-2感染

The application of antibody-based agents in cancer therapy based on their mechanisms of action

基于抗体药物作用机制的癌症治疗应用

Dual-target immunotherapies in NSCLC: a systematic review and meta-analysis of randomized clinical trials

非小细胞肺癌双靶点免疫疗法：随机临床试验的系统评价和荟萃分析

Protective effects of an Fc-engineered PD-L1 fusion protein in a spontaneous abortion model and a Th17 cell-induced pregnancy loss model

Fc工程化PD-L1融合蛋白在自然流产模型和Th17细胞诱导的妊娠丢失模型中的保护作用

Small extracellular vesicles purification and scale-up

小细胞外囊泡的纯化和放大

Exosomes: the next frontier in vaccine development and delivery

外泌体：疫苗研发和递送的下一个前沿领域

The therapeutic potential of exosomes in immunotherapy

外泌体在免疫治疗中的治疗潜力

Engineered soluble ACE2 receptor: Responding to change with change

工程化可溶性ACE2受体：以变革应对变革